Efficacy of PD-1 and PD-L1 inhibitors in older adults: A meta-analysis

被引：4
|
作者：
Elias, Rawad
Giobbie-Hurder, Anita
Rahma, Osama E.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e21544
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21544
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Soluble PD-L1 levels correlate with efficacy of PD-1/PD-L1 inhibitors in lung cancer
    Kang, Da Hyun
    Koh, Jeong Suk
    Chung, Chaeuk
    Park, Dongil
    Lee, Song-I
    Lee, Jeong Eun
    [J]. RESPIROLOGY, 2023, 28 : 99 - 99
  • [32] PD-1/PD-L1 Inhibitors Monotherapy for the Treatment of Endometrial Cancer: Meta-Analysis and Systematic Review
    Dai, Yun
    Muaibati, Munawaer
    Xie, Weiming
    Abasi, Abuduyilimu
    Li, Kexin
    Tong, Qing
    Zhang, Tao
    Meng, Yifan
    Zhuang, Liang
    Huang, Xiaoyuan
    [J]. CANCER INVESTIGATION, 2022, 40 (03) : 293 - 309
  • [33] Predictive value of tumor mutational burden for PD-1/PD-L1 inhibitors in NSCLC: A meta-analysis
    Li, Wenjie
    Zhao, Yanjun
    Zhang, Hongjun
    Zheng, Wenying
    Wang, Ruixuan
    Gu, Xing
    [J]. MEDICINE, 2023, 102 (40) : E34990
  • [34] Cardiovascular Toxicity With PD-1/PD-L1 Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis
    Liu, Surui
    Gao, Wei
    Ning, Yan
    Zou, Xiaomeng
    Zhang, Weike
    Zeng, Liangjie
    Liu, Jie
    [J]. FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] Patient-Reported Outcomes with PD-1/PD-L1 Inhibitors for Advanced Cancer: A Meta-Analysis
    Nishuima, Tomohiro F.
    Shachar, Shlomit S.
    Muss, Hyman B.
    Tamura, Kazuo
    [J]. ONCOLOGIST, 2019, 24 (07): : E565 - E573
  • [36] Evaluation of PD-L1 biomarker for immune checkpoint inhibitor (PD-1/PD-L1 inhibitors) treatments for urothelial carcinoma patients: A meta-analysis
    Rui, Xin
    Gu, Ting-Ting
    Pan, Hua-Feng
    Zhang, Hui-Zhi
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 67 : 378 - 385
  • [37] Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors in the treatment of hepatocellular carcinoma: A meta-analysis and systematic review
    Zhang, Baoyan
    Su, Linfeng
    Lin, Yonghua
    [J]. ONCOLOGY LETTERS, 2024, 28 (01)
  • [38] Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in colorectal cancer: a meta-analysis
    Jin, Chunhui
    Zhu, Xiaodan
    Huang, Xiaona
    Gong, Tingjie
    Wei, Zhipeng
    You, Jianliang
    [J]. JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2021, 11 (03) : 203 - 212
  • [39] Efficacy of PD-1/PD-L1 Inhibitors versus Chemotherapy in Lung Cancer with Brain Metastases: A Systematic Review and Meta-Analysis
    Yang, Xiaojun
    Zeng, Yihong
    Tan, Qinquan
    Huang, Zhihua
    Jia, Jun
    Jiang, Guanming
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2022, 2022
  • [40] The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis
    Wang, Bi-Cheng
    Cao, Ru-Bo
    Fu, Chen
    Chen, Wang-Bing
    Li, Pin-Dong
    Lin, Guo-He
    Qian, Xiao-Jun
    Li, Yun-Tian
    Liu, Quentin
    [J]. ORAL ONCOLOGY, 2020, 104
12345